Previous Close | 1.3500 |
Open | 1.3500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 10.00 |
Expire Date | 2024-10-18 |
Day's Range | 1.3500 - 1.3500 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York.
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2024.